200 related articles for article (PubMed ID: 2556174)
1. Comparative intragastric pH profile of Algicon versus Gaviscon.
Stoddard CJ; Morgan GE
Br J Clin Pract Suppl; 1989 Feb; 66():29-34; discussion 35-6. PubMed ID: 2556174
[No Abstract] [Full Text] [Related]
2. Gastric pH and endoscopic appearance after Algicon administration.
Lambert JR; Korman MG; Nicholson L
Br J Clin Pract Suppl; 1989 Feb; 66():25-8; discussion 35-6. PubMed ID: 2511920
[No Abstract] [Full Text] [Related]
3. [pH gradient support and antacid action of gastroesophageal coating agents. In vitro pharmacologic study using a model of "the artificial stomach"].
Vatier J; Vitre MT; Vallot T; Mignon M
Gastroenterol Clin Biol; 1990; 14(5):414-22. PubMed ID: 2163935
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.
Ward AE
Br J Clin Pract Suppl; 1989 Feb; 66():52-5; discussion 61-4. PubMed ID: 2556176
[No Abstract] [Full Text] [Related]
5. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
[No Abstract] [Full Text] [Related]
6. Algicon in the management of gastro-oesophageal reflux.
Lambert JR; Korman MG; Nicholson L
Br J Clin Pract Suppl; 1989 Feb; 66():56-8; discussion 61-4. PubMed ID: 2556177
[No Abstract] [Full Text] [Related]
7. The mode of action alginic acid compound in the reduction of gastroesophageal reflux.
Malmud LS; Charkes ND; Littlefield J; Reilley J; Stern H; Rosenberg R; Fisher RS
J Nucl Med; 1979 Oct; 20(10):1023-8. PubMed ID: 231639
[TBL] [Abstract][Full Text] [Related]
8. [Bioavailability of orally administered iron. Effects of alginate/antacid administration].
Campo S; Breda E
Minerva Med; 1992 Mar; 83(3):145-7. PubMed ID: 1553063
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of gastro-esophageal reflux using a potable gaviscon suspension].
Guerre J; Neuman M; Bouchet J
Med Chir Dig; 1982; 11(4):289-95. PubMed ID: 6287126
[No Abstract] [Full Text] [Related]
10. [In vitro studies of antacids. I].
Schnekenburger J
Arzneimittelforschung; 1974 Feb; 24(2):142-4. PubMed ID: 4406362
[No Abstract] [Full Text] [Related]
11. In-vivo anti-reflux and raft properties of alginates.
Lambert JR; Korman MG; Nicholson L; Chan JG
Aliment Pharmacol Ther; 1990 Dec; 4(6):615-22. PubMed ID: 2129648
[TBL] [Abstract][Full Text] [Related]
12. A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon Suspension.
Washington N; Greaves JL; Iftikhar SY
Aliment Pharmacol Ther; 1992 Oct; 6(5):579-88. PubMed ID: 1420749
[TBL] [Abstract][Full Text] [Related]
13. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
Mandel KG; Daggy BP; Brodie DA; Jacoby HI
Aliment Pharmacol Ther; 2000 Jun; 14(6):669-90. PubMed ID: 10848650
[TBL] [Abstract][Full Text] [Related]
14. [Gaviscon].
Ménégol-Couque B; Brard M
Soins; 1985 Jun; (455):I-II. PubMed ID: 2994235
[No Abstract] [Full Text] [Related]
15. [Chemico-physical property and bile acid binding capacity of several antacids].
Salvioli G; Tambara E; Gaetti E; Lugli R
Minerva Dietol Gastroenterol; 1989; 35(2):79-83. PubMed ID: 2548124
[TBL] [Abstract][Full Text] [Related]
16. [Effect of antacids on mineral metabolism in persons with healthy kidneys. Double-blind study using an antacid containing magnesium aluminum silicate hydrate].
Herzog P; Holtermüller KH
MMW Munch Med Wochenschr; 1982 Oct; 124(42):921-3. PubMed ID: 6298611
[No Abstract] [Full Text] [Related]
17. Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy.
Lang GD; Dougall A
Br J Clin Pract Suppl; 1989 Feb; 66():48-51; discussion 61-4. PubMed ID: 2556175
[No Abstract] [Full Text] [Related]
18. The mode of action and complications of Infant Gaviscon.
Keipert JA
Aust Paediatr J; 1979 Dec; 15(4):263-5. PubMed ID: 44677
[No Abstract] [Full Text] [Related]
19. [Gastroesophageal reflux. Results of a multicenter study of 170 patients on the therapeutic value of the Gaviscon drinkable suspension].
Chevrel B
Med Chir Dig; 1980; 9(6):535-9. PubMed ID: 6259459
[No Abstract] [Full Text] [Related]
20. Gaviscon bezoars.
Sorbie AL; Symon DN; Stockdale EJ
Arch Dis Child; 1984 Sep; 59(9):905-6. PubMed ID: 6091569
[No Abstract] [Full Text] [Related]
[Next] [New Search]
